New business for N. Vardinogiannis

AVE is also entering chemicals through the newly established BACOBAN. Who is participating in the new scheme, the capital of 200,000 euros and the range of activities from disinfectants and cleaners to pharmaceutical products.

New business for N. Vardinogiannis

This article is an AI translation of an original piece published in Greek. Read original

One more business is being added to the portfolio of AVE, the group of interests of Nikos Th. Vardinogiannis, this time with a focus on chemical products. On September 17, BACOBAN S.A. was established, headquartered in Pallini and with initial share capital of 200,000 euros, having as its main activity the wholesale trade of chemical products and as a secondary activity their production.

The connection with AVE goes through Cyprus. The largest shareholder of BACOBAN is AVE Participation Limited, which contributes 102,000 euros and acquires 102,000 of the total 200,000 shares, that is, 51% of the new company.

AVE Participation is a 100% subsidiary of the listed AVE S.A., according also to the latter's financial statements. The remaining 49% is divided among four natural persons and one company. Vasileios Klis and Charalambos Laoudis contribute 31,000 euros each and acquire 15.5% each, Georgios Sagonas 16,000 euros for 8%, Evangelia Roumba 10,000 euros for 5%, while another 5% is acquired by Prime Tax Advisors with a contribution of 10,000 euros.

BACOBAN may engage in the production and trade of chemical products, soaps, detergents, cleaning products and disinfectants, as well as in the production of medicines and pharmaceutical preparations.

Its scope also includes pharmaceutical and parapharmaceutical products, medical technology items, cosmetics and personal care products. As well as cleaning and disinfection services in professional and industrial spaces, hospitals, clinics, ships and participation in public and private tenders.

In its first board of directors, Thomas Roumbas assumes the role of chairman and Ioannis Klis that of chief executive officer, while the board also includes Charalambos Laoudis, Georgios Sagonas, Dimitrios Metaxas, Apostolos Voulgaris and Ioannis Stamatakos.

v
Privacy